News coverage about St Jude Medical (NYSE:STJ) has trended somewhat positive recently, according to Accern Sentiment. The research group identifies negative and positive news coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. St Jude Medical earned a news impact score of 0.10 on Accern’s scale. Accern also assigned media coverage about the medical technology company an impact score of 45.7105591032119 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near term.
Shares of STJ traded up $0.13 during midday trading on Thursday, hitting $80.82. The stock had a trading volume of 14,736,199 shares, compared to its average volume of 8,538,350. The company has a debt-to-equity ratio of 1.20, a current ratio of 1.93 and a quick ratio of 1.31. St Jude Medical has a twelve month low of $48.83 and a twelve month high of $84.00.
About St Jude Medical
St. Jude Medical, Inc is focused on the development, manufacture and distribution of cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas, and interventional pain therapy and neurostimulation devices for the management of chronic pain and movement disorders.
Receive News & Ratings for St Jude Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for St Jude Medical and related companies with MarketBeat.com's FREE daily email newsletter.